A report released today by the Commonwealth Fund confirms what has long been the common wisdom about drug prices in this country: Americans pay more for brand-name prescription medications than do residents of most other countries.
Putting policy and procedures into place is one of the best ways to navigate compliance in the novel area between healthcare and technology, says Sara Helene Shanti, a partner in Sheppard Mullin’s Corporate Practice Group in Chicago.
The Food and Drug Administration is sounding the warning bell on counterfeit versions of the weight loss medication Ozempic, saying fakes cause possible infection risks. The agency said it has seized thousands of units of the product, which has crept its way into the legitimate U.S. drug supply chain.
The respiratory disease known as respiratory syncytial virus (RSV) has led to more emergency hospitalizations than the flu and the Omicron variant of COVID-19, according to recent findings in JAMA.
Blue Shield of California is reducing its staffing by 140 positions, or about 2% of the workforce.
The National Association of ACOs is asking for changes to the information blocking rule prohibiting participation in the Medicare Shared Savings Program if the ACO or its clinicians for noncompliance.
Note: Andreessen Horowitz says views expressed by its employees are their own and should not be taken as investment advice. More details at https://a16z.com/disclosures/
A trend from 2023 that appears determined to persist into the new year is cybersecurity risk, as a Missouri hospital’s computer systems were disrupted at the end of December, forcing the facility to take its computer systems offline. Liberty Hospital became aware of the disruption on December 19, at which time it took its entire […]
Interest rates are expected to fall in 2024, changing the healthcare investment landscape moving into the new year, according to Bret Schiller, head of Healthcare Corporate Client Banking & Specialized Industries at J.P. Morgan. “We think that rate cuts will start by the second, third quarter,” Schiller said.
The year may be new, but the concerns about COVID-19 are old: A new study in JAMA shows that people who have been hospitalized with COVID-19 perform worse on cognitive and neurological tests, suggesting impaired brain function.